Wegmans Recalls Various Prepared Foods That Contain Hard-Cooked Eggs

Wegmans Food Markets, Inc. is recalling hard-cooked eggs, as well as prepared foods that contain hard-cooked eggs, sold between January 23 and February 1, 2012 because the eggs have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.  

This recall only affects purchases made at Wegmans’ Rochester, Buffalo, Syracuse, Canandaigua, Newark, Geneva, Corning, Elmira, Geneseo, and  Hornell stores.  It came about as the result of a recent recall by Minnesota-based Michael Foods, Inc., which produces the cooked eggs at its Wakefield, Nebraska facility.

The following affected products sold in Wegmans prepared foods and deli departments are included in the recall:
Hard-Cooked Eggs (sold by the pound in prepared foods or as a choice on the Fresh Foods Bar)    

Eggs (special-order deli tray or 6-pack, 12 pack)
Cobb Salad (10 oz, 43 oz, and 6.5 lb)
Garden Salad (10 oz, 20 oz, 2 lb, and 5 lb)
Baby Spinach Salad (9 oz, 1.8 lb, and 3.9 lb)
Chef Salad (9 oz. and 18 oz.)
Egg Salad (sold by the pound in prepared foods)
Egg Salad Sub (Sub Shop)
Kosher Macaroni Salad (sold by the pound in kosher deli)
Kosher Pickled Eggs (sold by the pound in kosher deli)

There have been no confirmed reports of illness in connection with these products. Wegmans has placed automated phone calls to customers who purchased the products using their Shoppers Club card.

According to Michael Foods, the recall was initiated after lab testing revealed that some of the eggs within the recalled lot dates may have been contaminated with Listeria monocytogenes. A recall of three lot dates was announced on Thursday, January 26, but Wegmans had not received any of the three initial lot codes. As a precautionary measure, the recall was expanded on February 1 to include additional lot dates, one of which was received by Wegmans. Michael Foods reached the decision to expand this recall after a thorough investigation which indicated a specific repair project that took place in the packaging room as the likely source of the contamination. The company has taken a number of corrective steps to address the issue and prevent recurrence.

Because these are fresh products with a very short shelf life, it is likely they have already been consumed.  However, consumers who may still have the product in their homes should discard it and return to the service desk for a refund.  If consumers have additional questions or concerns, please contact Wegmans at (800) 934-6267   (800) 934-6267, and ask for consumer affairs, M – F, 8 am to 5 pm EST.

Strangulation & Death – King International Recalls the Shoulderflex Massager

In cooperation with the Food and Drug Administration (FDA), King International LLC Is initiating a recall of the Shoulderflex massager due to a report of a strangulation and death. Consumers, retailers and catalog sellers are being advised to immediately stop using Shoulderflex massagers, and to safely dispose of them in the trash.

This announcement relates to all of the approximately 12,000 Shouderflex massagers which were sold between 2003 and 2011. The devices were sold at various stores (including Relax the Back), in catalogs (including Lifestyle Fascination), and online retailers (including Amazon) in the United States.

King International advises that the device components be disposed of separately so that the massager cannot be reassembled and used. The most effective way to do that is to dispose of the power supply separate from the massager unit, and to remove the massage fingers and dispose of them separately.

This is a voluntary recall program conducted by King International as part of its commitment to safety. There has been a report of a strangulation and death. There was a warning never to wear a necklace to avoid entanglement. King International shares FDA’s desire to take prompt action to reduce the risk of injury. Accordingly, King International asks customers to immediately stop using Shoulderflex massagers and to safely dispose of them in the trash, and for retailers and catalog sellers to take similar action.

Additional information about this recall campaign can be obtained from King International LLC at (503) 524-7046 (www.shoulderflex.com) or by writing to King International at PO Box 2384, Beaverton, OR 97075.

Defibtech Announces a Voluntary Recall of DDU-100 series AEDs

Contact:

Consumer:

877-453-4507

techsupport@defibtech.com

Media:

Ray Valek

708-352-8695

ray@defibtech.com

FOR IMMEDIATE RELEASE – April 29, 2011 – Defibtech, LLC is initiating a worldwide voluntary recall of certain DDU-100 series semi-automatic external defibrillators (AEDs) sold under the Lifeline AED and ReviveR AED brand names, including 65,885 AEDs distributed in the United States. This recall affects only DDU-100 Series AEDs shipped with 2.004 software or earlier. This corrective action addresses two possible conditions, which in rare cases may cause an affected AED to cancel shock during the charging process and not provide therapy which may result in failure to resuscitate the patient. Both conditions are not detectable by the periodic self test.

Condition 1: In rare instances, the AED may cancel charge in preparation for a shock. Based on field data, the odds of an affected AED having this happen are less than a 1 in 400,000 chance per month for any given AED.

A subset of AEDs (less than 11%) that are affected by Condition 1 are also affected by Condition 2: In rare instances, the AED may cancel charge in preparation for a shock in very high humidity conditions. The only reported cases were in environments of greater than 95% relative humidity or condensing conditions. Based on field data, the odds of an affected AED having this happen are less than a 1 in 250,000 chance per month for any given affected AED.

Defibtech will provide customers with a free software upgrade to address these issues. The correction to the AED will be able to be performed at the location where the AED is deployed.

Because both of these conditions occur very rarely, it is recommended that customers keep their AEDs in service until they have performed the software upgrade. Full instructions and recommendations are being mailed to affected customers. This customer notification, as well as instructions on determining whether an AED is affected, can also be found on the www.defibtech.com/fa11web page. For additional information regarding this recall, please refer to the above referenced web page, contact your distributor, or contact Defibtech at techsupport@defibtech.com, 1-877-453-4507 or 1-203-453-4507.

The AEDs affected by this recall have been distributed globally to fire departments, EMS, health clubs, schools, and other organizations. The Food and Drug Administration (FDA) has determined that this action is a Class I recall. Any adverse reactions experienced with the use of this product and/or quality problems should also be reported to the FDA’s MedWatch Program by phone at 1-800- FDA-1088, or on the MedWatch website at www.fda.gov/medwatch.

Alfalfa Sprouts Recalled Because of Possible Health Risk

Jonathans Sprouts of Rochester, MA is upgrading its recall of conventional alfalfa sprout products with a specific sell-by date to include all of its alfalfa products, conventional and organic, with all sell-by dates, as a precaution, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonellacan result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

Six products are involved:

• Jonathan’s 4oz Alfalfa Sprouts – all sell-by dates
• Jonathan’s 4oz Organic Alfalfa Sprouts – all sell-by dates
• Jonathan’s 4oz Alfalfa with Radish Sprouts – all sell-by dates
• Jonathan’s 4oz Organic Alfalfa with Radish Sprouts – all sell-by dates
• Jonathan’s 4oz Gourmet Sprouts – all sell-by dates
• Jonathan’s 4oz Alfalfa with Dill Sprouts – all sell-by dates
• Jonathan’s 8oz Alfalfa Sprouts – all sell-by dates
• Jonathan’s Organic Sprout Salad – all sell by dates

The product is sold in plastic containers, approximately 4 inches cube. See attached photographs.

They are sold at the following stores:

A&P, Grand Union, Stop & Shop, Shaws, Hannaford, Donnelans, Foodmaster, Truccis, Roche Brothers

The product being recalled was identified through routine sampling as part of the USDA Microbiological Data Program.

Consumers who have purchased Jonathans Sprouts products containing alfalfa sprouts are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 508-763-2577 .

Headache for Rolaids(R)?

McNeil Consumer Healthcare Announces Voluntary Recall Of All Lots Of Rolaids® Extra Strength Softchews, Roldaids® Extra Strength Plus Gas Softchews, And Roldaids® Multi-Symptom Plus Anti-Gas Softchews Sold In The United States

 Contact:
McNeil Consumer Healthcare
http://www.rolaids.com⁹
1-888-222-6036  
McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling all lots of ROLAIDS® Extra Strength Softchews, ROLAIDS® Extra Strength plus Gas Softchews, and ROLAIDS® Multi-Symptom plus Anti-Gas Softchews (full product details below) distributed in the United States. McNeil is taking this action following some consumer reports of foreign materials in the product, including metal and wood particles. The company’s investigation has determined that the materials were potentially introduced into the product during the manufacturing process at a third party manufacturer. While the risk of serious adverse health consequences is remote, McNeil Consumer Healthcare advises consumers who have purchased these recalled products to discontinue use.

While our investigation is ongoing we have suspended production of ROLAIDS® Extra Strength Softchews, ROLAIDS® Extra Strength plus Gas Softchews, and ROLAIDS® Multi-Symptom plus Anti-Gas Softchews and will not restart production until corrective actions have been implemented.

Consumers who purchased product included in this recall should contact McNeil Consumer Healthcare, either at http://www.rolaids.com¹⁰
or by calling 1-888-222-6036 begin_of_the_skype_highlighting              1-888-222-6036      end_of_the_skype_highlighting (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time) for instructions about receiving a refund. Consumers who have medical concerns or questions should contact their healthcare provider.

Any adverse reactions may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
 Online: http://www.fda.gov/MedWatch/report.htm¹¹
Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: http://www.fda.gov/MedWatch/getforms.htm¹².
Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

Product Information: Product NDC numbers can be located on the label of the package above the brand name. Lot Numbers and Expiration Dates can be found on back, side or bottom label of the package. If you cannot find the NDC number, lot number, or expiration date on the label, Click here¹³ for examples or call the Consumer Care Center at 1-888-222-6036
CLICK HERE¹⁴ TO FIND OUT IF YOUR ROLAIDS® SOFTCHEWS PRODUCT IS PART OF THE DECEMBER 9, 2010 RECALL.

FULL RECALLED PRODUCT LIST:

Product Name	Lot Number	UPC
ROLAIDS® Extra Strength Softchews, Wild Cherry
ROLAIDS® Extra Strength Softchews, Wild Cherry, 6 count	9015A, 9016A, 9019A, 9140A, 9138A,9210A, 9211A,9315A, 9316A	312547655200
ROLAIDS® Extra Strength Softchews, Wild Cherry, 18 count (3 packs of 6 count)	9075A, 9076A, 9103A, 9098A, 9104A, 9239A, 9240A, 9348A	312547655255
ROLAIDS® Extra Strength Softchews, Wild Cherry, 42 count (7 packs of 6 count)	9065A, 9068A, 9069A, 9131A, 9132A, 9208A, 9209A, 9286A, 9287A	312547655316
ROLAIDS® Extra Strength Softchews, Cherry
ROLAIDS® Extra Strength Softchews, Cherry, 6 count	0109A, 0114A, 0115A, 0134A, 0135A, 0165A, 0238B, 0239A, 0239C, 0262A, 0264A	312547655200
ROLAIDS® Extra Strength Softchews, Cherry, 18 count bag	9349AG2, 9350AG1, 0015AG2, 0015AG3, 0050AG1, 0051AG1, 0053BG2, 0106BG2, 0107AG1, 0108AG1, 0108BG3, 0108CG1, 0129BG1, 0133AG1, 0133AG2, 0165BG2, 0191BG1, 0191CG1, 0191DG1, 0213AG2, 0238AG1, 0238AG2, 0246AG1	300450649188
ROLAIDS® Extra Strength Softchews, Cherry, 36 count bag	9350AG2, 0012AG1, 0013AG1, 0014AG1, 0015AG1, 0015AG4, 0050AG2, 0053AG2, 0053BG1, 0053BG2, 0094AG1, 0106AG1, 0106BG1, 0108AG2, 0108BG2, 0191AG1, 0139BG2, 0165BG1, 0191BG1, 0207AG1, 0207AG2, 0213AG1, 0227AG1, 0246AG2, 0247AG1, 0265AG1, 0266AG1	300450649362
ROLAIDS® Extra Strength plus Gas Softchews, Tropical Fruit
ROLAIDS® Extra Strength plus Gas Softchews, Tropical Fruit, 6 count	9005A, 9006A	312547065733
ROLAIDS® Extra Strength plus Gas Softchews, Tropical Fruit, 12 count (2 packs of 6 count)	9022A, 9027A, 9118A, 9119A, 9195A, 9196A	312547065757
ROLAIDS® Extra Strength plus Gas Softchews, Tropical Fruit, 36 count (6 packs of 6 count)	9166A, 9167A	312547065771
ROLAIDS® Multi-Symptom plus Anti-Gas Softchews, Tropical Fruit
ROLAIDS® Multi-Symptom plus Anti-Gas Softchews, Tropical Fruit, 6 count	0017B, 0095A, 0096B, 0259A, 0260A	300450657060
ROLAIDS® Multi-Symptom plus Anti-Gas Softchews, Tropical Fruit, 12 count bag	9351BG1, 9352AG1, 0016AG1, 0059AG2, 0059BG1, 0059BG2, 0060AG2, 0167AG2, 0167AG3, 0203AG1, 0204AG1	300450657121
ROLAIDS® Multi-Symptom plus Anti-Gas Softchews, Tropical Fruit, 24 count bag	9352AG2, 9352BG2, 0016AG2, 0017AG1, 0057BG1, 0058AG1, 0059AG1, 0059BG3, 0060AG1, 0129AG1, 0132AG1, 0167AG1, 0167BG1, 0204AG2, 0205AG1, 0230AG1, 0231AG1	300450657244

CLICK HERE¹⁵ TO FIND OUT IF YOUR ROLAIDS® SOFTCHEWS PRODUCT IS PART OF THE DECEMBER 9, 2010 RECALL.

CLICK HERE¹⁶ FOR A REFUND OF YOUR PRODUCT

CLICK HERE¹⁷ TO SEE FREQUENTLY ASKED QUESTIONS

CLICK HERE¹⁸ FOR INFORMATION ABOUT RECALLS OF ROLAIDS® AND OTHER PRODUCTS

Del Bueno Recalls Cheese Because Of Possible Health Risk

 

Contact:
Del Bueno
Del Bueno of Grandview, WA is recalling all size packages of Queso Fresco Fresh Cheese, Queso Panela Fresh Cheese, Requeson Mexican Style Ricotta Cheese, and Queso Enchilado Dry Cheese because they have the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.  Although healthy individuals may suffer only short-term symptoms such as fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.

Fresh Mexican Cheese

Del Bueno distributed the cheese to retail markets in Washington and Oregon and to the flea market in Pasco, WA. 

The following products are being recalled:

• Queso Fresco Fresh Cheese, UPC 75318225028 for 16 oz. package, UPC 753182814063 for 3 lbs. package, date code up to and including Feb 10 2011.
• Queso Panela Fresh Cheese, UPC 753182814056, date code up to and including Feb 10 2011.
• Requeson Mexican Style Ricotta Cheese, UPC 753182814070, date code up to and including Jan 10 2011
• Queso Enchilado Dry Cheese, no UPC date code up to and including Mar 15 2011.

The date code is stamped on the back of the packages.  This date code is to signify the expiration date.  The cheese is packaged either in 1 lb. or 3 lbs. plastic vacuum bags. 

No illnesses have been reported to date.

The recall is the result of the environmental samples and finished product samples by Food and Drug Administration (FDA) and the result of the finished product samples by Washington State Department of Agriculture (WSDA).  The test results revealed that the cheeses are contaminated with Listeria monocytogenes.

Del Bueno has notified their customers and has pulled the products from retail stores.  The firm is working with FDA to conduct the recall.

Consumers who have purchased Del Bueno brand cheeses are urged to return them to the place of purchase for a full refund.  Consumers with questions may contact Del Bueno at 425-503-3823

Has Advertising Gone Too Far? Class Actions on the Rise

Take this pill and you’ll lose fifty pounds in two hours. Drink this juice and you’re sex life will never be the same. Class action lawsuits for misleading advertising are on the rise. So, we’re asking, “what’s your opinion?” Are these lawsuits the result of a bad economy whose consumers expect more for their money? Are they a sign that consumers are fed up with over-the-top advertising and finally fighting back?; or Is the legal system to blame? You tell us.  

It’s practically impossible to go an entire day without being exposed to some sort of advertisement.  As consumers, we must filter advertisements by reading between the lines and filling in the blanks. While it’s illegal for advertisers to deceive or mislead consumers, the line between what is truthful and what is misleading can often be quite fine.

Both the federal government and state government(s) have laws that make it illegal to use false, misleading, and/or deceptive claims. These laws apply to claims about the quality, nature, price, or purpose of any product or service. The Federal Trade Commission (FTC) is the federal agency that regulates false and misleading advertising. Even though the FTC, federal laws, and state laws exist, it seems that many advertisements manage to slip through the cracks. 

Just recently, New York Attorney General Andrew Cuomo started cracking down on car dealerships for misleading advertisements about the “cash for clunkers” program. According to the New York Post, the Attorney General’s office issued letters to 40 dealerships across the state, ordering them to stop putting out advertisements that mislead or don’t fully explain how the federal program works. All 40 dealerships ran ads that omitted the eligibility requirements that must be met before a consumer can receive the federally funded cash. Cuomo believes these dealerships misled consumers into thinking certain cars qualified for the trade-in rebate.

This is not the first time that Cuomo has gone after faulty advertisements. He reached a $300,000 settlement with the “facial-firming” company Lifestyle Lift because they posted fake consumer reviews online. Also, his office came to a 2.63 million agreement with AT&T Mobility over a misleading sales promotion involving rebate offers on cell phones and other wireless equipment.

A 2008 Federal Judicial Center report indicates that “consumer protection/fraud” class actions in the federal courts have increased dramatically. The proof: in 2001 there were 191 and in 2007 there were 489. Consumer lawyers state that companies may be implementing questionable advertisements in an effort to offset the bad economy and poor sales. As a result, such advertisements often mislead and deceive consumers. However, defense lawyers believe the arrival of a democratic president has energized the Federal Trade Commission (FTC) to regulate with a more rigid eye. While many think the FTC is more strict under the new administration, the FTC maintains that they have always been aggressive in their pursuit against deceptive advertising. The only area the FTC does admit to focusing is behavioral advertising, the practice of tracking online users’ activity for target ads. 

Consumers aren’t going to take it. When companies use deceptive tactics to boost sales it can actually backfire. Two well-known companies, Kraft Foods Inc. and Dannon Co., now face class action lawsuits. The suit against Kraft was recently filed in New Jersey state court. It alleges that Kraft unlawfully concealed from consumers that hot dogs increase the risk for cancer. Danon Co. faces class action lawsuits in several states, all based on the allegation that it overstated the health benefits of its probiotic yogurt products (Activia and DanActive).

In the federal court system, a class action lawsuit has been brought against the manufacturers of ExtenZe. The lawsuit accuses the maker of the natural male enhancement pill of making both false and misleading claims about the product’s ability to actually provide sexual enhancement for men.  

What is your take on the subject? Most of us don’t hesitate to return a product when we are dissatisfied, but when it comes to taking legal action we think twice. Have advertising tactics gone too far or are Consumers, state AG’s, federal regulators, and lawyers being too critical?

Serious Side Effects Associated with Levaquin

The fluroquinolone antibiotic Levaquin, used to treat lung, sinus, skin, and urinary tract infections caused by certain bacteria. FDA recently ordered the makers of Levaquin to include a black box warning on the drug after reports of severe Levaquin side effects related to painful tendon and ligament injuries.

The Levaquin side effects resulting in this black box warning include tendonitis and tendon ruptures, both of which can be very painful and debilitating. Patients may not realize they are experiencing such side effects until it is too late.

If you are taking Levaquin you should discuss these possible side effects with your doctor. If you have been taking Levaquin and have experienced pain in your tendons, ligaments or joints, you should consult with your doctor immediately about a possible link between the drug and your symptoms.

From USRecallNews.com

Yamaha ATV Recall Warning

Yamaha Motor Corp. issued a recall of over $120,000 Yamaha ATV’s in March 2009. All Rhino 450 and 660 model ATV’s are being recalled for repairs.

Yamaha Rhino 450

There have been at least 46 deaths attributed to the Rhino 450, 660 and 700 models, most of them involving rollover accidents, according to the U.S. Consumer Product Safety Commission (CPSC), which advised consumers to stop using the ATVs until the repair is completed. About 120,000 of the 450 and 660 model Rhinos which have been distributed nationwide since Fall 2003 are now being recalled for repairs. Yamaha’s repair includes the installation of a spacer on the rear wheels as well as the removal of the rear anti-sway bar to help reduce the chance of rollover and improve vehicle handling, and continued installation of half doors and additional passenger handholds where these features have not been previously installed to help keep occupants’ arms and legs inside the vehicle during a rollover and reduce injuries.

Owners of the affected Rhinos should stop using them and call their dealer to schedule an appointment to have the repairs made and to take advantage of a free helmet offer. Yamaha is also implementing the same repair program and suspension of sale for the Rhino 700 model. About 25,000 Rhino 700s are included.

http://www.consumeraffairs.com/recalls04/2009/rhino.html#ixzz0KUo3YaF3

Enteryx Warning

GASTROESOPHAGEAL REFLUX DISEASE (GERD) SUFFERERS

If you or a loved one suffers from GERD and was treated with Enteryx to prevent reflux and suffered an adverse event or death from this drug contact Eichen Levinson for a free consultation.

Recall of Enteryx Injections for Gastroesophageal Reflux Disease

FDA recently issued Public Health Notification about serious adverse events, including death, occurring with Enteryx, a product made by Boston Scientific that’s used to treat gastroesophageal reflux disease (GERD). Enteryx is a liquid copolymer that’s injected into the muscle layer of the lower esophageal sphincter. Shortly after injection, it solidifies into a spongy material that acts as a physical barrier to help prevent reflux. Once injected, the material can not be removed.

The serious adverse events involved unrecognized transmural injections of Enteryx i.e., cases where the injection needle may have penetrated the esophageal wall, injecting the material into the wall of the aorta, the mediastinum and the pleural cavity. In some cases, this was not recognized until several weeks after the injection took place. There were other cases where injury occurred even though the Enteryx was not injected transmurally. These injuries included serious mediastinal events and esophageal stenosis.

If symptoms do occur, x-ray or CT exams should be done to rule out transmural injection. Patients should go to an emergency room immediately if they experience chest pain or syncope.

<div id=”_mcePaste” style=”position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px; overflow-x: hidden; overflow-y: hidden;”>If symptoms do occur, x-ray or CT exams should be done to rule out transmural injection. Patients should go to an emergency room immediately if they experience chest pain or syncope.</div>If you or a loved one suffers from GERD and was treated with Enteryx to prevent reflux and suffered an adverse event or death from this drug contact Eichen Levinson for a free consultation.

Recall of Enteryx Injections for Gastroesophageal Reflux Disease

FDA recently issued Public Health Notification about serious adverse events, including death, occurring with Enteryx, a product made by Boston Scientific that’s used to treat gastroesophageal reflux disease (GERD). Enteryx is a liquid copolymer that’s injected into the muscle layer of the lower esophageal sphincter. Shortly after injection, it solidifies into a spongy material that acts as a physical barrier to help prevent reflux. Once injected, the material can not be removed. The serious adverse events involved unrecognized transmural injections of Enteryx i.e., cases where the injection needle may have penetrated the esophageal wall, injecting the material into the wall of the aorta, the mediastinum and the pleural cavity. In some cases, this was not recognized until several weeks after the injection took place. There were other cases where injury occurred even though the Enteryx was not injected transmurally. These injuries included serious mediastinal events and esophageal stenosis.

If symptoms do occur, x-ray or CT exams should be done to rule out transmural injection. Patients should go to an emergency room immediately if they experience chest pain or syncope.